Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
FULC Price Trend and Signals
FULC Option Volumes & Open Interests (aggregated)
FULC Put Call Ratios and IV (aggregated)
FULC Financials
2025-10-02Somewhat Bullishprice_signal
Yearly high detected.
2025-10-01Somewhat Bullishprice_signal
Yearly high detected.
2025-09-30Somewhat Bullishprice_signal
Yearly high detected.
2025-09-26Somewhat Bullishprice_signal
Yearly high detected.
2025-09-25Somewhat Bullishprice_signal
Yearly high detected.
2025-09-24Somewhat Bullishprice_signal
Yearly high detected.
2025-09-19Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-09-19Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-09-19Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.